Novo Nordisk expects Catalent deal to close later this year

COPENHAGEN (Reuters) – Novo Nordisk expects to close its acquisition of Catalent later this year, its chief financial officer said during the company’s capital markets day on Thursday, adding that Novo’s gross margin is seen falling in the coming years.

(Reporting by Maggie Fick, writing by Louise Breusch Rasmussen, Editing by Elaine Hardcastle)